Afshar-Oromieh A, Holland-Letz T, Giesel FL, Kratochwil C, Mier W, Haufe S et al (2017) Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients. Eur J Nucl Med Mol Imaging 44(8):1258–1268
Barrio M, Czernin J, Fanti S, Ambrosini V, Binse I, Du L et al (2017) The impact of Somatostatin receptor-directed PET/CT on the Management of Patients with Neuroendocrine tumor: a systematic review and meta-analysis. J Nucl Med 58(5):756–761
Article
PubMed
Google Scholar
Baum RP, Kulkarni HR, Schuchardt C, Singh A, Wirtz M, Wiessalla S et al (2016) 177Lu-labeled prostate-specific membrane antigen Radioligand therapy of metastatic castration-resistant prostate cancer: safety and efficacy. J Nucl Med 57(7):1006–1013
Article
CAS
PubMed
Google Scholar
Baumann T, Rottenburger C, Nicolas G, Wild D (2016) Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - imaging and staging. Best Pract Res Clin Endocrinol Metab 30(1):45–57
Article
PubMed
Google Scholar
Becker AS, Marcon M, Ghafoor S, Wurnig MC, Frauenfelder T, Boss A (2017) Deep learning in mammography: diagnostic accuracy of a multipurpose image analysis software in the detection of breast cancer. Investig Radiol 52(7):434–440
Article
Google Scholar
Bouma H, Sonnemans JJ, Vilanova A, Gerritsen FA (2009) Automatic detection of pulmonary embolism in CTA images. IEEE Trans Med Imaging 28(8):1223–1230
Article
PubMed
Google Scholar
Bouyeure-Petit AC, Chastan M, Edet-Sanson A, Becker S, Thureau S, Houivet E et al (2017) Clinical respiratory motion correction software (reconstruct, register and averaged-RRA), for 18F-FDG-PET-CT: phantom validation, practical implications and patient evaluation. Br J Radiol 90(1070):20160549
Article
PubMed
Google Scholar
Brauer A, Grubert LS, Roll W, Schrader AJ, Schafers M, Bogemann M et al (2017) 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging 44(10):1663–1670
Cai W, Tabbara M, Takata N, Yoshida H, Harris GJ, Novelline RA et al (2009) MDCT for automated detection and measurement of pneumothoraces in trauma patients. AJR Am J Roentgenol 192(3):830–836
Article
PubMed
Google Scholar
Calais J, Czernin J, Eiber M, Fendler WP, Gartmann J, Heaney AP et al (2017) Most of the intended management changes after 68Ga-DOTATATE PET/CT are implemented. J Nucl Med 58(11):1793–1796
Article
PubMed
Google Scholar
Chen Y, An H (2017) Attenuation correction of PET/MR imaging. Magn Reson Imaging Clin N Am 25(2):245–255
Article
PubMed
Google Scholar
Cicero M, Bilbily A, Colak E, Dowdell T, Gray B, Perampaladas K et al (2017) Training and validating a deep Convolutional neural network for computer-aided detection and classification of abnormalities on frontal chest radiographs. Investig Radiol 52(5):281–287
Article
Google Scholar
Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I et al (2016) Simultaneous 68Ga-PSMA HBED-CC PET/MRI improves the localization of primary prostate cancer. Eur Urol 70(5):829–836
Article
CAS
PubMed
Google Scholar
El Fakhri G, Surti S, Trott CM, Scheuermann J, Karp JS (2011) Improvement in lesion detection with whole-body oncologic time-of-flight PET. J Nucl Med 52(3):347–353
Article
PubMed
PubMed Central
Google Scholar
Explorer: University of California Davis; [Available from: http://explorer.ucdavis.edu/. Accessed 22 Dec 2017
Fendler WP, Czernin J, Herrmann K, Beyer T (2016) Variations in PET/MRI operations: results from an international survey among 39 active sites. J Nucl Med 57(12):2016–2021
Article
PubMed
PubMed Central
Google Scholar
Ghayoor A, Vaidya JG (2017) Johnson HJ. Robust automated constellation-based landmark detection in human brain imaging. NeuroImage Epub ahead of print
Henry KE, Ulaner GA, Lewis JS (2017) Human epidermal growth factor receptor 2-targeted PET/single- photon emission computed tomography imaging of breast cancer: noninvasive measurement of a biomarker integral to tumor treatment and prognosis. PET clinics 12(3):269–288
Article
PubMed
PubMed Central
Google Scholar
Hoefnagel LD, van der Groep P, van de Vijver MJ, Boers JE, Wesseling P, Wesseling J et al (2013) Discordance in ERalpha, PR and HER2 receptor status across different distant breast cancer metastases within the same patient. Ann Oncol 24(12):3017–3023
Article
CAS
PubMed
Google Scholar
Hogan MP, Goldman DA, Dashevsky B, Riedl CC, Gonen M, Osborne JR et al (2015) Comparison of 18F-FDG PET/CT for systemic staging of newly diagnosed invasive lobular carcinoma versus invasive Ductal carcinoma. J Nucl Med 56(11):1674–1680
Article
CAS
PubMed
PubMed Central
Google Scholar
Huesch MD, Mosher TJ. Using it or losing it? The case for data scientists inside health care NEJM catalyst 2017 [Available from: https://catalyst.nejm.org/case-data-scientists-inside-health-care/. Accessed 22 Dec 2017
Kairemo K, Kangasmaki A (2013) 4D SPECT/CT acquisition for 3D dose calculation and dose planning in (177)Lu-peptide receptor radionuclide therapy: applications for clinical routine. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer 194:537–550
CAS
PubMed
Google Scholar
Kesner AL, Chung JH, Lind KE, Kwak JJ, Lynch D, Burckhardt D et al (2016) Frequency based gating: an alternative, conformal, approach to 4D PET data utilization. Med Phys 43(3):1451–1461
Article
PubMed
Google Scholar
Lakhani P, Sundaram B (2017) Deep learning at chest radiography: automated classification of pulmonary tuberculosis by using Convolutional neural networks. Radiology 284(2):574–582
Liu J, Chen Z, Wang T, Liu L, Zhao L, Guo G et al (2016) Influence of four radiotracers in PET/CT on diagnostic accuracy for prostate cancer: a Bivariate random-effects meta-analysis. Cell Physiol Biochem 39(2):467–480
Article
CAS
PubMed
Google Scholar
Mestel R (2017) Cancer: imaging with antibodies. Nature 543(7647):743–746
Article
CAS
PubMed
Google Scholar
Moradi E, Pepe A, Gaser C, Huttunen H, Tohka J (2015) Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects. NeuroImage 104:398–412
Article
PubMed
Google Scholar
Nanni C, Zanoni L, Pultrone C, Schiavina R, Brunocilla E, Lodi F et al (2016) (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial. Eur J Nucl Med Mol Imaging 43(9):1601–1610
Article
CAS
PubMed
Google Scholar
Paik S, Kim C, Wolmark N (2008) HER2 status and benefit from adjuvant trastuzumab in breast cancer. N Engl J Med 358(13):1409–1411
Article
CAS
PubMed
Google Scholar
Pandit-Taskar N, Veach DR, Fox JJ, Scher HI, Morris MJ, Larson SM (2016) Evaluation of castration-resistant prostate cancer with androgen receptor-Axis imaging. J Nucl Med 57(Suppl 3):73s–78s
Article
PubMed
Google Scholar
Pepin A, Daouk J, Bailly P, Hapdey S, Meyer ME (2014) Management of respiratory motion in PET/computed tomography: the state of the art. Nucl Med Commun 35(2):113–122
Article
PubMed
PubMed Central
Google Scholar
Priedigkeit N, Hartmaier RJ, Chen Y, Vareslija D, Basudan A, Watters RJ et al (2017) Intrinsic subtype switching and acquired ERBB2/HER2 amplifications and mutations in breast cancer brain metastases. JAMA oncology 3(5):666–671
Article
PubMed
Google Scholar
Rahbar K, Ahmadzadehfar H, Kratochwil C, Haberkorn U, Schafers M, Essler M et al (2017) German multicenter study investigating 177Lu-PSMA-617 Radioligand therapy in advanced prostate cancer patients. J Nucl Med 58(1):85–90
Article
PubMed
Google Scholar
Rathkopf DE, Morris MJ, Fox JJ, Danila DC, Slovin SF, Hager JH et al (2013) Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer. J Clin Oncol 31(28):3525–3530
Article
CAS
PubMed
PubMed Central
Google Scholar
Rauscher I, Maurer T, Beer AJ, Graner FP, Haller B, Weirich G et al (2016) Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage Lymphadenectomy. J Nucl Med 57(11):1713–1719
Article
PubMed
Google Scholar
Ristau BT, O'Keefe DS, Bacich DJ (2014) The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research. Urol Oncol 32(3):272–279
Article
PubMed
Google Scholar
Rossi S, Basso M, Strippoli A, Dadduzio V, Cerchiaro E, Barile R et al (2015) Hormone receptor status and HER2 expression in primary breast cancer compared with synchronous Axillary metastases or recurrent metastatic disease. Clinical breast cancer 15(5):307–312
Article
CAS
PubMed
Google Scholar
Sadowski SM, Neychev V, Millo C, Shih J, Nilubol N, Herscovitch P et al (2016) Prospective study of 68Ga-DOTATATE positron emission tomography/computed tomography for detecting gastro-Entero-pancreatic Neuroendocrine tumors and unknown primary sites. J Clin Oncol 34(6):588–596
Article
CAS
PubMed
Google Scholar
Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B et al (2017) Phase 3 trial of 177Lu-Dotatate for Midgut Neuroendocrine tumors. N Engl J Med 376(2):125–135
Article
CAS
PubMed
Google Scholar
Summers RM (2016) Progress in fully automated abdominal CT interpretation. AJR Am J Roentgenol 207(1):67–79
Article
PubMed
PubMed Central
Google Scholar
Ulaner GA, Castillo R, Wills J, Gonen M, Goldman DA (2017) 18F-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer. Eur J Nucl Med Mol Imaging 44(9):1420–1427
Article
CAS
PubMed
Google Scholar
Ulaner GA, Goldman DA, Corben A, Lyashchenko SK, Gonen M, Lewis JS et al (2017) Prospective clinical trial of 18F-Fluciclovine PET/CT for determining the response to Neoadjuvant therapy in invasive Ductal and invasive lobular breast cancers. J Nucl Med 58(7):1037–1042
Article
PubMed
Google Scholar
Ulaner GA, Goldman DA, Gonen M, Pham H, Castillo R, Lyashchenko SK et al (2016) Initial results of a prospective clinical trial of 18F-Fluciclovine PET/CT in newly diagnosed invasive Ductal and invasive lobular breast cancers. J Nucl Med 57(9):1350–1356
Article
CAS
PubMed
Google Scholar
Ulaner GA, Hyman DM, Lyashchenko SK, Lewis JS, Carrasquillo JA (2017) 89Zr-trastuzumab PET/CT for detection of HER2-positive metastases in patients with HER2-negative primary breast cancer. Clin Nucl Med 42(12):912–917
Ulaner GA, Hyman DM, Ross DS, Corben A, Chandarlapaty S, Goldfarb S et al (2016) Detection of HER2-positive metastases in patients with HER2-negative primary breast cancer using 89Zr-Trastuzumab PET/CT. J Nucl Med 57(10):1523–1528
Article
PubMed
PubMed Central
Google Scholar
Ulaner GA, Riedl CC, Dickler MN, Jhaveri K, Pandit-Taskar N, Weber W (2016) Molecular imaging of biomarkers in breast cancer. J Nucl Med 57 Suppl 1:53s–59s
Article
PubMed
Google Scholar
Vandenberghe S, Mikhaylova E, D'Hoe E, Mollet P, Karp JS (2016) Recent developments in time-of-flight PET. EJNMMI physics 3(1):3
Article
CAS
PubMed
PubMed Central
Google Scholar
Vargas HA, Wassberg C, Fox JJ, Wibmer A, Goldman DA, Kuk D et al (2014) Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival. Radiology 271(1):220–229
Article
PubMed
Google Scholar
Wang Y, Ayres KL, Goldman DA, Dickler MN, Bardia A, Mayer IA et al (2016) 18F–Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials. Clin Cancer Res 23(12):3053–3060
Wibmer AG, Burger IA, Sala E, Hricak H, Weber WA, Vargas HA (2016) Molecular imaging of prostate cancer. Radiographics 36(1):142–159
Article
PubMed
Google Scholar
Yamamoto M, Ficke DC, Ter-Pogossian MM (1982) Experimental assessment of the gain achieved by the utilization of time-of-flight information in a positron emission Tomograph (super PETT I). IEEE Trans Med Imaging 1(3):187–192
Article
CAS
PubMed
Google Scholar
Yoon HJ, Kang KW, Chun IK, Cho N, Im SA, Jeong S et al (2014) Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from (6)(8)Ga-RGD PET/CT and (1)(8)F-FDG PET/CT. Eur J Nucl Med Mol Imaging 41(8):1534–1543
Article
CAS
PubMed
Google Scholar